FTC's Slaughter says Fresenius-NxStage settlement gives companies 'near-monopoly' in hemodialysis machines
MLex Summary: Federal Trade Commission Commissioner Rebecca Slaughter said the FTC's settlement of the Fresenius-NxStage merger leaves the combined company with a "monopoly or near-monopoly position for the manufacturing and sale...To view the full article, register now.
Already a subscriber? Click here to view full article